CEACAM5 and neoplasm: Taken together, conversion surgery could be beneficial regardless of disease burden at diagnosis, including tumor size, biopsy histology, metastatic pattern, and CEA level, but BMI and molecular markers of targeted therapies are critical for selecting patients for conversion surgery.